Kinetics of Circulating Progenitor Cells and Chemotactic Factors in Full-Term Neonates with Encephalopathy: Indications of Participation in the Endogenous Regenerative Process

Preclinical studies have shown that progenitor cells (PCs) are mobilized toward injured tissues to ameliorate damage and contribute to regeneration. The exogenous therapeutic administration of PCs in children affected by neonatal encephalopathy (NE) is a promising, yet underreported, topic. In this...

Full description

Saved in:
Bibliographic Details
Main Authors: Nikolaos Efstathiou, Georgios Koliakos, Katerina Kantziou, Georgios Kyriazis, Aristeidis Slavakis, Vasiliki Drossou, Vasiliki Soubasi
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/15/3/427
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850204339283427328
author Nikolaos Efstathiou
Georgios Koliakos
Katerina Kantziou
Georgios Kyriazis
Aristeidis Slavakis
Vasiliki Drossou
Vasiliki Soubasi
author_facet Nikolaos Efstathiou
Georgios Koliakos
Katerina Kantziou
Georgios Kyriazis
Aristeidis Slavakis
Vasiliki Drossou
Vasiliki Soubasi
author_sort Nikolaos Efstathiou
collection DOAJ
description Preclinical studies have shown that progenitor cells (PCs) are mobilized toward injured tissues to ameliorate damage and contribute to regeneration. The exogenous therapeutic administration of PCs in children affected by neonatal encephalopathy (NE) is a promising, yet underreported, topic. In this prospective study, we investigated whether endogenous circulating progenitor cells (CPCs) are involved in intrinsic regeneration mechanisms following neonatal brain injury. Thirteen full-term infants with moderate/severe NE, eleven with perinatal stress, and twelve controls were enrolled. Blood samples were collected on days 1, 3, 9, 18, and 45, as well as at 8 and 24 months of life, and were analyzed with a focus on Endothelial Progenitor Cells, Haematopoietic Stem Cells, and Very Small Embryonic-Like Stem Cells, in addition to chemotactic factors (erythropoietin, IGF-1, and SDF-1). Correlations between CPCs, chemotactic factors, and brain injury were assessed using serum levels of brain injury biomarkers (S100B and neuron-specific enolase), brain MRIs, and Bayley III developmental scores. Increased brain injury biomarkers were followed by the upregulation of SDF-1 receptor and erythropoietin and, finally, by elevated CPCs. These findings suggest a potential endogenous regenerative effort, primarily observed in the moderate encephalopathy group, but this is suppressed in cases of severe brain injury. Mimicking and enhancing endogenous regeneration pathways in cases of failure—regarding cell type and timeframe—could provide a novel therapeutic model.
format Article
id doaj-art-4329baef0d0d4b65a9e6b7ae4560d35b
institution OA Journals
issn 2218-273X
language English
publishDate 2025-03-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj-art-4329baef0d0d4b65a9e6b7ae4560d35b2025-08-20T02:11:18ZengMDPI AGBiomolecules2218-273X2025-03-0115342710.3390/biom15030427Kinetics of Circulating Progenitor Cells and Chemotactic Factors in Full-Term Neonates with Encephalopathy: Indications of Participation in the Endogenous Regenerative ProcessNikolaos Efstathiou0Georgios Koliakos1Katerina Kantziou2Georgios Kyriazis3Aristeidis Slavakis4Vasiliki Drossou5Vasiliki Soubasi61st Neonatal Clinic and NICU, Hippokration General Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, GreeceBiochemistry Department, Medical School, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece1st Neonatal Clinic and NICU, Hippokration General Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, GreeceImmunology Department, Pulmonary Clinic, Papanikolaou General Hospital, Aristotle University of Thessaloniki, Exohi, 57010 Thessaloniki, GreeceBiochemistry Department, Hippokration General Hospital, 54642 Thessaloniki, Greece1st Neonatal Clinic and NICU, Hippokration General Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece1st Neonatal Clinic and NICU, Hippokration General Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, GreecePreclinical studies have shown that progenitor cells (PCs) are mobilized toward injured tissues to ameliorate damage and contribute to regeneration. The exogenous therapeutic administration of PCs in children affected by neonatal encephalopathy (NE) is a promising, yet underreported, topic. In this prospective study, we investigated whether endogenous circulating progenitor cells (CPCs) are involved in intrinsic regeneration mechanisms following neonatal brain injury. Thirteen full-term infants with moderate/severe NE, eleven with perinatal stress, and twelve controls were enrolled. Blood samples were collected on days 1, 3, 9, 18, and 45, as well as at 8 and 24 months of life, and were analyzed with a focus on Endothelial Progenitor Cells, Haematopoietic Stem Cells, and Very Small Embryonic-Like Stem Cells, in addition to chemotactic factors (erythropoietin, IGF-1, and SDF-1). Correlations between CPCs, chemotactic factors, and brain injury were assessed using serum levels of brain injury biomarkers (S100B and neuron-specific enolase), brain MRIs, and Bayley III developmental scores. Increased brain injury biomarkers were followed by the upregulation of SDF-1 receptor and erythropoietin and, finally, by elevated CPCs. These findings suggest a potential endogenous regenerative effort, primarily observed in the moderate encephalopathy group, but this is suppressed in cases of severe brain injury. Mimicking and enhancing endogenous regeneration pathways in cases of failure—regarding cell type and timeframe—could provide a novel therapeutic model.https://www.mdpi.com/2218-273X/15/3/427progenitor cellsneonateencephalopathyfull-termbraincirculating
spellingShingle Nikolaos Efstathiou
Georgios Koliakos
Katerina Kantziou
Georgios Kyriazis
Aristeidis Slavakis
Vasiliki Drossou
Vasiliki Soubasi
Kinetics of Circulating Progenitor Cells and Chemotactic Factors in Full-Term Neonates with Encephalopathy: Indications of Participation in the Endogenous Regenerative Process
Biomolecules
progenitor cells
neonate
encephalopathy
full-term
brain
circulating
title Kinetics of Circulating Progenitor Cells and Chemotactic Factors in Full-Term Neonates with Encephalopathy: Indications of Participation in the Endogenous Regenerative Process
title_full Kinetics of Circulating Progenitor Cells and Chemotactic Factors in Full-Term Neonates with Encephalopathy: Indications of Participation in the Endogenous Regenerative Process
title_fullStr Kinetics of Circulating Progenitor Cells and Chemotactic Factors in Full-Term Neonates with Encephalopathy: Indications of Participation in the Endogenous Regenerative Process
title_full_unstemmed Kinetics of Circulating Progenitor Cells and Chemotactic Factors in Full-Term Neonates with Encephalopathy: Indications of Participation in the Endogenous Regenerative Process
title_short Kinetics of Circulating Progenitor Cells and Chemotactic Factors in Full-Term Neonates with Encephalopathy: Indications of Participation in the Endogenous Regenerative Process
title_sort kinetics of circulating progenitor cells and chemotactic factors in full term neonates with encephalopathy indications of participation in the endogenous regenerative process
topic progenitor cells
neonate
encephalopathy
full-term
brain
circulating
url https://www.mdpi.com/2218-273X/15/3/427
work_keys_str_mv AT nikolaosefstathiou kineticsofcirculatingprogenitorcellsandchemotacticfactorsinfulltermneonateswithencephalopathyindicationsofparticipationintheendogenousregenerativeprocess
AT georgioskoliakos kineticsofcirculatingprogenitorcellsandchemotacticfactorsinfulltermneonateswithencephalopathyindicationsofparticipationintheendogenousregenerativeprocess
AT katerinakantziou kineticsofcirculatingprogenitorcellsandchemotacticfactorsinfulltermneonateswithencephalopathyindicationsofparticipationintheendogenousregenerativeprocess
AT georgioskyriazis kineticsofcirculatingprogenitorcellsandchemotacticfactorsinfulltermneonateswithencephalopathyindicationsofparticipationintheendogenousregenerativeprocess
AT aristeidisslavakis kineticsofcirculatingprogenitorcellsandchemotacticfactorsinfulltermneonateswithencephalopathyindicationsofparticipationintheendogenousregenerativeprocess
AT vasilikidrossou kineticsofcirculatingprogenitorcellsandchemotacticfactorsinfulltermneonateswithencephalopathyindicationsofparticipationintheendogenousregenerativeprocess
AT vasilikisoubasi kineticsofcirculatingprogenitorcellsandchemotacticfactorsinfulltermneonateswithencephalopathyindicationsofparticipationintheendogenousregenerativeprocess